OPY Stock Recent News

Brian Nagel, Oppenheimer analyst, joins CNBC's 'Squawk on the Street' to discuss how companies can adapt their supply chains to account for new tariffs, whether it's feasible for companies to actually move their manufacturing to the U.S., and more.

SAN DIEGO , April 2, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that Jay Hagan, CEO, will participate in a presentation at the 2025 Oppenheimer Innovation on the Island Biotech Summit on Wednesday, April 9 th at 11:32 a.m. ET. The live event and replay of the presentation will be available under "Events and Presentations" through the investor relations section of the Company's website at https://ir.regulusrx.com/events and archived for 90 days following the presentation date.

Brian Nagel, Oppenheimer & Co. senior equity research analyst, joins 'Squawk Box' to break down Lululemon's quarterly earnings results.

NEW YORK , March 25, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. — a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Ranjot Singh has joined the Firm as a Managing Director in its Technology Investment Banking Group. He will be based in Oppenheimer's New York office and report to Robin Graham, Head of Technology Investment Banking.

The Investment Committee reveal their strategy in financials after Goldman Sachs catches a downgrade today.

The M&A bounce investors expected after U.S. President Donald Trump's return to the White House and hopes for light-touch regulation haven't happened, and one brokerage firm on Wednesday downgraded its rating on Wall Street giant Goldman Sachs (GS).

Oppenheimer Clients Can Now Invest in Gold, Silver, and Other Physical Precious Metals Through GBI's Integrated Platform NEW YORK , March 19, 2025 /PRNewswire/ -- GBI, the leading institutional platform for physical precious metals investments, today announced its strategic integration with Oppenheimer & Co. Inc., a leading investment bank and wealth management firm. Through this integration, Oppenheimer's clients will be able to diversify their portfolios by seamlessly investing in gold, silver, and other precious metals through GBI's cutting-edge GBI Platform, fully integrated into Oppenheimer's suite of wealth management services.

PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET.

LONDON , March 12, 2025 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a significant expansion to its European investment banking team with the addition of three highly experienced senior investment bankers in London. They join the firm from boutique Hannam & Partners and will report to Max Lami, CEO of Oppenheimer European business.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE:CYH) today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference to be held March 17 – 20, 2025, in a virtual format. The presentation will begin at 10:40 a.m. Eastern time, 9:40 a.m. Central time, on Tuesday, March 18, 2025, and will be available to investors via a live audio webcast. A link to the broadcast can be found at the investor relations section of th.